0.000USD0.000åå ŽååŒÂ 08/03, 09:30 (ET)
601.99MæäŸ¡ç·é¡
19.87çŽè¿12ã¶æPER
äž»èŠããŒã¿
4.170å§å€
4.210é«å€
2.99Måºæ¥é«
19.87çŽè¿12ã¶æPER
36.22äºæ³PER
--çŽè¿12ã¶æé
åœ
2.01%売買å転ç
4.270忥çµå€
3.973å®å€
7.76M売買代é
14.50æ ªäŸ¡åçç
2.53PBRïŒæ ªäŸ¡çŽè³ç£åçïŒ
0.00%çŽè¿12ã¶æé
åœå©åã
10.60%ç·è³ç£å©çç
7.99052é±é«å€
1.17åºæ¥é«æ¯ç%
42.42MçŽå©ç
148.93Mæ ªåŒæ°
0.20781æ ªåœããå©çïŒEPSïŒ
1.47ããŒã¿å€
13.77%èªå·±è³æ¬å©çç
3.02552é±å®å€
5.56%æ¯ãå¹
68.50%ç²å©çç
601.99MæäŸ¡ç·é¡
2.00ãªã¹ã¯ãªã¿ãŒã³
2.46%ãªã¹ã¯ç
é貚: USD æŽæ°æå»: 2026-07-31 äž»èŠã€ã³ãµã€ã
MiMedx Group Incã®ãã¡ã³ãã¡ã³ã¿ã«ãºã¯æ¯èŒçéåžžã«å¥å
šã§ããæé·ã®å¯èœæ§ã¯é¡èã§ããããªã¥ãšãŒã·ã§ã³ã¯é©æ£äŸ¡æ Œãšè©äŸ¡ãããŠããŸãããã€ãªãã¯ãããžãŒ & å»çç ç©¶æ¥çã§ã®é äœã¯385äž77äœã§ããæ©é¢æè³å®¶ä¿æçã¯éåžžã«é«ãã§ããéå»1ãæéã«è€æ°ã®ã¢ããªã¹ããè²·ããšè©äŸ¡ããæé«ç®æšæ ªäŸ¡ã¯6.60ãšãããŠããŸããäžæçã«ã¯ãæ ªäŸ¡ã¯äžæãã¬ã³ããšäºæ³ãããŸããéå»1ãæã®æ ªåŒåžå Žã®ããã©ãŒãã³ã¹ã¯å¹³åçã§ããããå瀟ã®ãã¡ã³ãã¡ã³ã¿ã«ãºã¯å
調ã§ããæ ªäŸ¡ã¯æ¯æç·ã𿵿ç·ã®éã§æšªã°ãæšç§»ããŠãããã¬ã³ãžçžå Žã§ã®ã¹ã€ã³ã°ãã¬ãŒãã«é©ããŠããŸãã
MiMedx Group Incã®ã¹ã³ã¢î°î°
ãµããŒãã©ã€ã³ãšã¬ãžã¹ã¿ã³ã¹ã©ã€ã³

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
éåžžã«äœã
éåžžã«é«ã
MiMedx Group Incã®æ³šç®ãã€ã³ã
匷ã¿ãªã¹ã¯
MiMedx Group Inc ãã¥ãŒã¹
ææ°æ
å ±ããåŸ
ã¡ãã ãã...
åçäºæž¬î
匷åè²·ã
è²·ã
äžç«
売ã
匷å売ã
Ionis Pharmaceuticals Inc
IONS
27
Kymera Therapeutics Inc
KYMR
24
ææšî
ææš
売ã(2)
äžç«(4)
è²·ã(0)
ç§»åå¹³å
売ã(4)
äžç«(0)
è²·ã(2)
è²¡åææšî
EPS

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
ç·å£²äžé«

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
MiMedx Group Incã®äŒæ¥æ
å ±î
MiMedx Group, Inc. is a placental biologics company focused on providing a portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. Its product portfolio categories include Wound Care and Surgical. The Wound Care products include EPIFIX and EPIEFFECT, which are marketed for external use, such as in advanced wound care applications. Its EPICORD, EPICORD Expandable and EPIEFFECT product lines also offer an alternative treatment option to address larger, deeper wounds. Its Surgical and Other product offering includes AMNIOFIX and AMNIOEFFECT, which are used in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery and multiple orthopedic repairs and reconstructions. It also offers HELIOGEN, an advanced bovine collagen matrix containing type I and type III collagen that is intended for the management of moderately to heavily exudating wounds and to control minor bleeding.
äŒæ¥ã³ãŒãMDXG
äŒæ¥åMiMedx Group Inc
æé«çµå¶è²¬ä»»è
ãCEOãCapper (Joseph H)
ãŠã§ããµã€ãhttps://mimedx.com/
æ ªäž»çµ±èšî
ãããã質å
MiMedx Group IncïŒMDXGïŒã®çŸåšã®æ ªäŸ¡ã¯ãããã§ããïŒ
îMiMedx Group IncïŒMDXGïŒã®çŸåšã®æ ªäŸ¡ã¯4.13ã§ãã
MiMedx Group Incã®ãã£ãã«ãŒã·ã³ãã«ã¯äœã§ããïŒ
îMiMedx Group Incã®ãã£ãã«ãŒã·ã³ãã«ã¯MDXGã§ãã
MiMedx Group Incã®52é±é«å€ã¯ãããã§ããïŒ
îMiMedx Group Incã®52é±é«å€ã¯7.99ã§ãã
MiMedx Group Incã®52é±å®å€ã¯ãããã§ããïŒ
îMiMedx Group Incã®52é±å®å€ã¯3.02ã§ãã
MiMedx Group Incã®æäŸ¡ç·é¡ã¯ãããã§ããïŒ
îMiMedx Group Incã®æäŸ¡ç·é¡ã¯601.99Mã§ãã
MiMedx Group Inc (MDXG) ã®çŸåšã®è©äŸ¡ã¯ãè²·ããããããŒã«ãããã売ããã®ã©ãã§ããïŒ
îã¢ããªã¹ãã«ãããšãMiMedx Group IncïŒMDXGïŒã®ç·åè©äŸ¡ã¯è²·ãã§ãç®æšæ ªäŸ¡ã¯6.60ã§ãã
MiMedx Group Inc (MDXG) ã®1æ ªåœããå©çïŒEPS TTMïŒã¯ãããã§ããïŒ
îMiMedx Group IncïŒMDXGïŒã®1æ ªåœããå©çïŒEPS TTMïŒã¯0.33ã§ãã